Accutane Lawsuit Loans

Have a Settled Accutane Lawsuit But Need Cash Now?

TriMark Legal Funding provides post-settlement funding on settled Accutane lawsuits nationwide.

Legal Funding on Settled Accutane Lawsuits

TriMark Legal Funding is one of America’s leading lawsuit funding companies. We provide post-settlement funding (lawsuit loans) to injured plaintiffs with settled Accutane cases nationwide while they wait for their settlements to payout.


Accutane Lawsuit Funding

At TriMark Legal Funding, we offer non-recourse lawsuit funding cash advances to plaintiffs who are involved in either pending or settled legal claims, often in 24 hours or less.

Lawsuit loans are a discreet, sensible way to keep your head above water until your attorney has finished negotiating your lawsuit settlement.

Let’s Talk!

Call us at (877) 932-2628 or send us your details & we’ll call you.

    This is a contact request form, not an application. If you would like to apply for funding, please click here.

    Have Questions?
    Call and speak with one of our funding experts today.

    Important Notice About Accutane Lawsuit Funding

    TriMark Legal Funding only offers post-settlement funding on settled Accutane lawsuits at this time

    This means that to qualify for funding consideration, you must have already signed your settlement agreement and know either

    1. The gross amount of your settlement OR
    2. The actual net amount you will be receiving after all deductions (attorney fees, case costs, medical liens, etc.)

    If you have a settled Accutane lawsuit and would like to apply for settlement funding, please apply here.

    How Lawsuit Loans Work

    TriMark Legal Funding specializes in helping personal injury accident victims.
    Our non-recourse legal funding is a simple 3-step process:

    1. Apply for Funding

    You can either apply online or call us toll-free at (877) 932-2628. We’ll answer all of your questions and gather some basic facts about your case.

    2. Review & Approval

    Our team will work directly with your attorney to review your case. Approvals can happen as quickly as 1 hour after receipt of all required information.

    3. Receive Cash

    A funding agreement is sent via DocuSign. After signed copies are returned, your cash is sent to you by wire transfer or FedEx Overnight.

    $0 UPFRONT FEES
    NO CREDIT CHECK

    Receive $1,000 to $250,000 in 4-24 hours after approval. No upfront or hidden fees and no hassles – EVER. You can relax while we work with your attorney to get you approved quickly.

    AMERICA’S ORIGINAL LOWEST RATE GUARANTEE

    On settled cases, we can offer capped, non-compounding rates of just over 2%.
    We will match or beat any competitor’s contract rate.

    100% RISK-FREE
    NO WIN = NO PAY

    Receive cash now but repay nothing until after your case settles. No monthly payments. Approval is based on the points and estimated net value of your case.

    Accutane Lawsuit Funding

    Generically known as Isotretinoin, this drug has been a popular anti-acne drug since it came on the market in 1982. It went “off-patent” in 2002 and has been available in generic prescription form under the following names: Amnesteem, Claravis, Decutan, Istane, Sotret, Ratane, RAccutane and the generic Isotretinoin. It was originally intended for the treatment of severe acne but many dermatologists prescribe the drug for off-label purposes.

    Acne treatment was created by Hoffman La Roche, a United States drug manufacturer. It is a synthetic form of Vitamin A that is made to alleviate severe acne symptoms. The La Roche Group is a leading pharmaceutical manufacturer bringing in $1.2 billion annually just for sales of Accutane.

    Serious side effects include:

    • Ulcerative Colitis
    • Crohn’s Disease
    • Depression
    • Erectile dysfunction (difficulty in maintaining erection)
    • Violent behavior/aggression
    • Psychosis (seeing or hearing things that are not real)
    • Suicide attempts
    • Hearing impairment
    • Osteopenia/osteoporosis (loss in bone mass and strength/weak and fragile bones)
    • Hepatotoxicity (liver damage)
    • Anaphylaxis (rapid and deadly allergic reaction)
    • Major birth defects
    • Cataracts/corneal opacities (can cause a decrease in vision and lead to eventual blindness)
    • Agranulocytosis (low white blood cells)
    • Inflammatory bowel disease
    • Pancreatitis
    • Vascular thrombosis (heart attack)
    • Stroke
    • Seizures

    Accutane Side Effects

    Recent studies have linked Accutane (known generically as Isotretinoin), a popular acne medication, to serious and painful side effects and gastrointestinal problems such as inflammatory Bowel Disease (IBD).   IBD is often characterized by conditions such as Ulcerative Colitis and Crohn’s disease and is associated with an increased risk of developing colorectal cancer. 

    In addition, studies have suggested Accutane may cause serious mental health problems (such as depression, psychosis, and suicide), birth defects, miscarriages, premature births, and  Stevens-Johnson Syndrome (severe skin reaction which can sometimes be fatal).
    Over 16 million people worldwide have used the drug since it was first approved by the FDA in 1982.  Accutane is used for the treatment of severe acne that is unresponsive to conventional therapy, including antibiotics.  

    On June 26, 2009, Hoffman-La Roche Pharmaceuticals voluntarily pulled the drug from the US market citing, among others reasons, the cost of defending against lawsuits.  Isotretinoin continues to be available as a generic and is also sold under a wide variety of names including Amnesteem, Claravis, and Sotret.
    There are dozens of know side effects, the most serious of which are gastrointestinal problems like inflammatory bowel disease, ulcerative colitis, and Crohn’s disease. Here is a full list of known Accutane side effects.

    Inflammatory Bowel Disease (IBD)

    People suffering from Inflammatory Bowel Disease (IBD) can experience the side effects many years after consuming the medication.  IBD is a general term that refers to a group of digestive disorders that can cause chronic inflammation or redness and swelling in the small and large intestines.  Symptoms often include abdominal pain and cramping, weight loss, poor appetite, fatigue, diarrhea (can be bloody), rectal bleeding, and fever.  Other IBD-related health problems may include: arthritis and joint pain, weak bones, and bone breaks, eye inflammation, liver inflammation, gallstones, skin ulcers or lesions, kidney stones, delayed puberty, and growth problems (in children and teens), and in rare cases, lung problems.

    The two major types of IBD are Crohn’s disease and Ulcerative Colitis.  Although they share similar symptoms they differ in that they affect different parts of the digestive tract.

    Crohn’s Disease and Ulcerative Colitis

    Crohn’s disease results in inflammation which usually affects all layers of the intestinal wall in the small and large intestines, as well as other digestive organs.  In contrast, ulcerative colitis results in inflammation and ulcers (sores) which usually affect the inner lining of the large intestine (colon) and rectum.  The big difference between the two being Crohn’s causes inflammation deeper within the intestinal wall whereas ulcerative colitis affects only the superficial top layer of the lining of the large intestine.  There is no cure for either disease and if drug therapy fails, which it often does, in treating these ailments then surgery is the only viable option.

    Accutane FDA Black Box Warning

    Isotretinoin was a pregnancy category X drug under the previous FDA system and is contraindicated in pregnant women or who may become pregnant. There have been severe, documented congenital disabilities when pregnant women have taken isotretinoin.

    The FDA issued a web page warning in 2007 and required a Black Box Warning label since 2003.   It is the strongest warning that the FDA requires.  A black box warning indicates that studies have found that the drug carries a significant risk of serious or even life-threatening adverse effects. The FDA required Hoffman-La Roche to place a black box warning on the labeling and in the literature describing it to help patients avoid serious adverse events.  In addition, the FDA now has stricter rules regarding the dispensation of Accutane. 

    Case Archive

    Archived cases are lawsuits that TriMark tracked or offered legal funding on at some point, but can no longer offer settlement funding on pending cases. While the majority of these lawsuits have been closed due to claim resolution and pre settlement funding is no longer available on them, some remain eligible for settled case funding.

    Check the pages below for more information and to see if lawsuit funding is still available from TriMark.



    Apply For Accutane Lawsuit Settled Case Funding

    Apply for Accutane settlement funding now!

    To qualify for an Accutane lawsuit cash advance, you must have a settled Accutane lawsuit. Pending lawsuits are not eligible at this time.

    To qualify, you must have an already signed Accutane settlement agreement which clearly shows either the gross amount of your settlement or the actual net amount you will be receiving after all deductions (attorney fees, case costs, medical liens, etc.) have been made.

    If you have a settled Accutane lawsuit and need funding, either:

    Call Us At (877) 932-2628 or


    Latest Developments in the Accutane Lawsuit…

    Roche has been on a legal roller coaster with its acne drug Accutane. Facing thousands of claims that the drug triggers inflammatory bowel disease, the Swiss drugmaker is now enjoying a high point, as an appeals court reversed a $25 million verdict against the company. In a lawsuit over a patient who developed Crohn's disease while taking the drug, a New Jersey appeals court ruled that the plaintiff, Andrew McCarrell, did not file his suit in time and that a lower court mistakenly applied New Jersey state law, rather than the law in McCarrell's home state of Alabama, the New Jersey Law Journal reports. The court used a precedent laid out in a 2012 Supreme Court ruling in favor of Johnson & Johnson, which dismissed a… Read more
    New Jersey judge has rejected Roche’s request for a new trial or reduction of a jury’s award of more than $25 million in damages for a man who developed severe inflammatory bowel disease from Accutane. In an order issued last week, Judge Carol Higbee denied Roche’s request for a new trial or remittitur in a case brought by Andrew McCarrell, which was one of the first Accutane lawsuits in the United States to reach a jury. McCarrell’s Accutane bowel disease suit was originally filed in 2003 and first went to trial in April 2007, resulting in a jury award of $2,619,000. However, following an appeal the verdict was overturned and the case was remanded for a new trial so that Roche would be permitted to introduce evidence on the… Read more
    Hagens Berman LLP, a nationally recognized law firm today praised a jury's verdict that ordered pharmaceutical company Roche to pay $2 million to a woman who suffered serious gastrointestinal damage caused by the drug Accutane, while denying similar claims of actor James Marshall and another plaintiff. Accutane, along with its active ingredient, isotretinoin, was approved by the Food and Drug Administration in 1982 to treat severe acne and became one of the biggest selling drugs for Roche with more than 16 million users. However, the drug's success has also been tainted by a history of more than 20 product-labeling modifications, FDA warning letters and litigation. The woman, Gillian Gaghan, took the drug and developed serious complications, including ulcerative colitis and lupus-like symptoms, and has lost nighttime bowel control, court… Read more
    A man who claimed that he developed severe bowel problems from Accutane, an acne medication, has reached a pre-trial settlement with Roche Laboratories, the drug’s manufacturer. Roche has asked Madison County Circuit Judge David Hylla to approve the Accutane settlement, according to a report in The Madison Record. The case, which was brought by plaintiff Jason Peipert, also involves a medical malpractice claim against an Illinois doctor, who may also be in settlement talks with the plaintiff. Peipert alleges that Dr. Daniel Goran prescribed him Accutane to treat his acne, and that the drug caused him to develop the debilitating condition, inflammatory bowel disease (IBD). The case was set to go to trial on April 19, but start of the trial was delayed due the potential settlement… Read more
    A New Jersey jury has awarded $25.16 million in damages in an Accutane lawsuit, which alleged that the acne drug caused the plaintiff to develop inflammatory bowel disease. The verdict was handed down this week in a New Jersey Superior Court, following the retrial of a case brought by Andrew McCarrell, 38, of Birmingham, Alabama. McCarrell originally won a $2.62 million award against Roche in 2007, but the company got that verdict overturned and the case was sent back for a retrial. Roche faces nearly 1,000 lawsuits over Accutane, which has been associated with bowel problems, depression and birth defects. All of the lawsuits include allegations that Roche failed to adequately warn users about potential Accutane side effects. The company has lost all six cases… Read more
    Accutane won't be sold any more, drug giant Hoffmann-La Roche Inc. has announced. Generic versions of the acne drug, called isotretinoin, are still available from several manufacturers. But Roche, which has sold the drug to 13 million patients since 1982, will not be one of them. The decision was made for "business reasons," Roche announced in a news release. Those reasons include declining sales: Accutane sales now make up less than 5% of the isotretinoin market. Another big reason: Accutane personal injury lawsuits, which Roche is aggressively defending. Accutane and other isotretinoin products are effective treatments for serious acne. But the drug can have extremely serious side effects: mental health problems — including depression, psychosis, and suicide — and, when taken by pregnant women, miscarriage or birth defects…. Read more

    See More

    Still have questions?

    Call (877) 932-2628 and speak with one of our legal funding experts.

    * Word-Use Disclaimer

    Legal funding is not a loan. It is the non-recourse purchase of an equitable lien in plaintiffs’ legal claims. Words such as ‘loans,’ ‘lending,’ ‘borrow,’ etc., are used for marketing purposes only.
    More info

    TriMark Legal Funding LLC
    1056 Green Acres Rd #102
    Eugene, OR 97408